🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in users injecting products of uncertain source.

Several experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the platform has removed problematic content and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Online Trading Operations

Research also discovered communities with up to nine thousand members selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at residence.

Within moments of entering one community, a vendor shared contact information, where the majority of transactions occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Details and Costs

Within these groups, posts show black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram said it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose users to possibly significant health risks”.